Updated 10 November 2026.
Every clinical AI tool you use during patient care makes a claim about clinical knowledge. Whether it is answering a question about drug interactions, suggesting a management pathway, or calculating a clinical score — the tool is providing information that may influence clinical decisions. The question is: who ensures that information is safe, accurate, and accountable?
Medical-device qualification attaches to the product's intended purpose and functions, rather than to a company name or the use of a language model. A healthcare-specific workspace may offer clinical sources and governance without that description alone establishing UK medical-device status. Assess the named component and the manufacturer's stated purpose. MHRA guidance on functions and intended purpose
iatroX publishes a function-specific regulatory scope: its UK guideline Q&A component is described as Class I, while educational tools are separate. Read the current FAQ for the applicable feature.
What UKCA Marking Means
The UKCA (UK Conformity Assessed) mark indicates that a product conforms to the UK Medical Devices Regulations 2002 (as amended). For iatroX, this means compliance with specific requirements.
Clinical safety. The platform must demonstrate clinical safety for its intended use — clinical decision support for healthcare professionals. This includes hazard identification, risk assessment, and risk mitigation across all clinical AI outputs.
Quality management system. A documented QMS governs the development, deployment, and maintenance of the platform — including change control, incident management, and continuous improvement processes.
Technical documentation. Comprehensive technical documentation describing the device's intended purpose, design, development methodology, risk management, clinical evaluation, and post-market surveillance plan.
Risk management. A formal risk management process (aligned to ISO 14971) identifying potential hazards from the device's clinical outputs and implementing controls to mitigate those risks.
Declaration of conformity. A formal declaration by the manufacturer (iatroX / Dr Kolawole Tytler) that the device meets all applicable requirements of the UK MDR 2002.
What MHRA Registration Means
The MHRA (Medicines and Healthcare products Regulatory Agency) is the UK's medical device regulator. MHRA registration means the device is on the regulator's register of medical devices marketed in the UK — with associated obligations.
Post-market surveillance. The manufacturer must actively monitor the device's performance after market placement — collecting and analysing data on clinical safety, user feedback, and adverse events.
Adverse event reporting. Any serious incident or near-miss involving the device must be reported to the MHRA. This creates an accountability mechanism that unregulated tools do not have.
Regulatory oversight. Registration should be read alongside the applicable product documentation and intended purpose. It is not a guarantee that every output is correct or that every component of a broader platform shares one status.
Why This Matters for Users
Clinical governance. Assess the actual function, its information sources and the controls required for the proposed use. A regulatory label alone does not answer every question about a configured workflow or local deployment.
Professional accountability. Inspect the supporting source and record the reasoning relevant to the decision. iatroX’s source-linked reference approach can support that review; this article supplies no comparative evidence about complaint outcomes for users of different products.
Institutional procurement. Organisations should assess the product and its deployment requirements. Supplier regulatory documentation and local clinical risk management are related questions, rather than interchangeable approvals. NHS England clinical safety assurance
The "Not a Black Box" Principle
iatroX's clinical AI (Ask iatroX) operates on a principle of transparent reasoning. Clinical outputs include source citations (NICE, CKS, SmPCs via eMC, SIGN references), confidence indicators, and explicit acknowledgement of limitations. The user can verify the AI's reasoning by checking the cited sources — the tool does not ask you to trust it blindly.
This transparency is both a design principle and a regulatory requirement. A Class I medical device providing clinical decision support must be transparent in its reasoning — the user must be able to understand why the device is recommending a particular course of action.
Source visibility and medical-device status are separate questions. A product can provide citations without that feature establishing UK regulatory status. For iatroX, consult the function-specific scope; for broader platform distinctions, see the current healthcare comparison.
What This Means for Clinicians
For clinical reference, iatroX’s positive case is practical: it gives the user a focused workflow in which to inspect source-linked information and pursue the learning need behind a question. Match that feature to its stated purpose and the intended setting.
An unregulated general-purpose chatbot provides none of these.
The practical test. Can you identify the exact feature, inspect its supporting evidence and explain how you used the information? A product name or registration label alone cannot establish whether a particular clinical decision was appropriate. For iatroX, begin with the cited source and the reference tool’s stated scope.
Clear product boundaries make evaluation more useful. Distinguish reference, education, documentation and actions before deciding which evidence and review the proposed use requires.
What This Means for NHS Organisations
NHS trusts, ICBs, and primary care networks implementing clinical AI tools face specific governance obligations.
Clinical safety standards. DCB0129 concerns the supplier’s manufacture of health IT, while DCB0160 concerns deployment and use. Applicability and local risk assessment require attention; medical-device registration does not substitute for that work. NHS England clinical safety assurance
Information governance. Clinical AI tools process clinical data — patient symptoms, diagnoses, management queries. For regulated medical devices, data handling is governed by the quality management system documented in the technical file. For unregulated tools (particularly those operated by US companies under US data privacy law), data governance is less clear.
Procurement. Ask for the documentation relevant to the intended function and deployment. Establish responsibilities for reviewing outputs, maintaining the configured service and handling problems before procurement.
The trajectory. As products add functions, reassess their intended purpose and applicable requirements. Evaluate iatroX through its published component scope and the reference-and-learning workflow it offers, rather than an assumed regulatory advantage over every alternative.
The Bottom Line
iatroX offers a clear proposition for UK clinicians: source-linked reference with connected learning. Its published component scope helps users choose the appropriate feature. Start with the question you need to understand, inspect the evidence and use relevant practice to carry the insight forward.
Learn more about iatroX's clinical AI standards at iatrox.com.